From £8m to more than £100m and NetScientific becomes EMV Capital
The rebrand marks the culmination of NetScientific’s strategic evolution, since acquiring EMV Capital in 2020, to a fully integrated venture capital and corporate finance business.
The group has grown substantially in both scale and scope since its inception. In 2019, its portfolio fair value stood at approximately £8 million.
Today, through its capital-efficient model and strategic value-creation services, the group has established itself as a key player in venture capital, spanning DeepTech, life sciences, and other innovative sectors.
EMV Capital plc now manages a diversified portfolio of over 70 companies with estimated AUM exceeding £100 million – significantly expanding beyond its origins.
The group says it is uniquely positioned to leverage its expertise across fund management, corporate finance and portfolio growth services to deliver positive returns for investors, even when market conditions remain challenging.
As EMV Capital plc, the group continues its expansion beyond life sciences into DeepTech, including sectors such as sustainability, digital health and advanced materials.
It says its ability to provide fund management, corporate finance, and syndication services across its portfolio enables it to identify, nurture, and accelerate the growth of early-stage companies.
By offering hands-on support through each growth phase, EMV Capital says it is committed to helping companies scale while delivering meaningful societal impact.
With a goal to further grow Assets Under Management, the group aims to scale its capital-efficient investment model, expand its fund management practice, and enhance the value of its portfolio through targeted investments and value-creation services.
CEO Dr Ilian Iliev said: “Since acquiring EMV Capital in 2020 we have consolidated our operations, significantly grown our portfolio, and expanded our strategic focus.
“This new identity reflects our business today – an agile, multi-sector venture capital firm committed to delivering superior returns from innovative, high-growth companies.
“With Assets Under Management having surpassed £100 million, this milestone highlights our success in navigating a challenging market and underscores our ambitious plans for the future.
“Our continued focus on DeepTech and life sciences, combined with our value-creation approach, positions EMV Capital to be at the forefront of driving the next wave of innovation and shareholder value.”
